BDBM361091 (3R)-3-{[4-(2-amino-1H-1,3-benzodiazol-4-yl)-2-sulfamoyl-3-(2H-1,2,3,4-tetrazol-5-yl)benzene]sulfonamido}-1-(2-aminoethyl)-1-methylpyrrolidin-1-ium; methaneperoxoate::US10221163, Example 248::US10544130, Example 249

SMILES C[N]1(CCN)CC[C@@H](C1)NS(=O)(=O)c1ccc(-c2cccc3[nH]c(N)nc23)c(-c2nn[nH]n2)c1S(N)(=O)=O

InChI Key InChIKey=FUYNLYBAFQVTLQ-FWJVZWRSSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 361091   

TargetBeta-lactamase()
Merck Sharp & Dohme

US Patent
LigandPNGBDBM361091((3R)-3-{[4-(2-amino-1H-1,3-benzodiazol-4-yl)-2-sul...)
Affinity DataIC50:  0.0610nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent